30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report
Cordoba A, Nickers P, Tresch E, Castelain B, Leblanc E, Narducci F, Le Tinier F, Lesoin A, Lacornerie T, Lartigau E | Rep Pract Oncol Radiother | 2015
Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study
Arians N, Kieser M, Benner L, Rochet N, Schröder L, Katayama S, Herfarth K, Schubert K, Schneeweiss A, Sohn C, Lindel K, Debus J | Radiat Oncol | 2019
Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer
Kim S, Lee S, Hong JH, Park YJ, Song JY, Lee JK, Lee NW | J Gynecol Oncol | 2020
Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer
Mukai Y, Minagawa Y, Inoue H, Sato A, Matsui K, Fukuda T, Onuma K, Hongo H, Shirata R, Nagata H, Hashimoto H, Inoue T, Hata M, Omura M | In Vivo | 2020
Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity
Zhang G, He F, Miao L, Wu H, Zhang Y, Fu C | Jpn J Clin Oncol | 2021
Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer
Ye X, Ye P, Zheng Y, Xia W | J BUON | 2021
The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC, and Huang MY | Radiat Oncol | 2022
Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer – PubMed (nih.gov)
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022
High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Tomita N, Soga N, Ogura Y, Hayashi N, Kageyama T, Ito M, Koide Y, Yoshida M, Kimura K, Makita C, Tachibana H, Kodaira T | J Cancer Res Clin Oncol | 2016
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C | Clin Oncol | 2016
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
Yamazaki H, Masui K, Suzuki G, Nakamura S, Shimizu D, Nishikawa T, Okabe H, Yoshida K, Kotsuma T, Tanaka E, Otani K, Yoshioka Y, Ogawa K | Cancers (Basel) | 2018
Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study
Onishi M, Kawamura H, Murata K, Inoue T, Murata H, Takakusagi Y, Okonogi N, Ohkubo Y, Okamoto M, Kaminuma T, Sekihara T, Nakano T, Ohno T | Cancers (Basel) | 2021
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
Ferrera G, D’Alessandro S, Cuccia F, Serretta V, Trapani G, Savoca G, Mortellaro G, Lo Casto A | J Cancer Res Clin Oncol | 2022
Moderate Hypofractionated Helical TomoTherapy for Older Patients with Localized Prostate Cancer: Long-term Outcomes of a Phase I-II Trial
Cui D, Du L, Yu W, Cai B, Meng L, Yang J, Luo Y, Chen J, and Ma L | Radiol Oncol| 2022
Impact of the VOLO Optimizer on Treatment Plan Quality of Stereotactic Prostate Radiotherapy
T. Viren, J. Seppälä | PO-2052 | ESTRO | 2023
Stereotactic Radiotherapy of Prostate Cancer Patients – Two Techniques Comparison: Preliminary Results
Aleksandra Napieralska, Wojciech Majewski, Marcela Krzempek, Grzegorz Woźniak, Marcin Miszczyk, Małgorzata Kraszkiewicz, Agnieszka Namysł-Kaletka | PO-2047 | ESTRO | 2023
Stereotactic Body Re-irradiation for Bone Metastases
Laura Giannini, Federica Ferrario, Miriam Torrisi, Chiara Chissotti, Chiara Lucrezia Deantoni, Sara Broggi, Lucia Perna, Claudio Fiorino, Martina Midulla, Stefano Lorenzo Villa, Italo Dell’Oca, Andrei Fodor, Antonella Del Vecchio, Stefano Arcangeli, Nadia Gisella Di Muzio | PO-1596 | ESTRO | 2023
Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases
Federica Ferrario, Miriam Torrisi, Chiara Chissotti, Laura Giannini, Chiara Lucrezia Deantoni, Sara Broggi, Martina Midulla, Stefano Lorenzo Villa, Italo Dell’Oca, Andrei Fodor, Claudio Fiorino, Antonella Del Vecchio, Stefano Arcangeli, Nadia Gisella Di Muzio | PO-1595 | ESTRO | 2023
Stereotactic Salvage Radiotherapy for Prostate Bed Relapse, Early Analysis from a Prospective Trial
Giulio Francolini, Luca Burchini, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Giulio Frosini, Barbara Guerrieri, Michele Ganovelli, Andrea Allegra, Viola Salvestrini, Luca Visani, Emanuela Olmetto, Carlotta Becherini, Gabriele Simontacchi, Manuele Roghi, Maria Grazia Carnevale, Isacco Desideri, Icro Meattini, Lorenzo Livi | PO-1459 | ESTRO | 2023
Stereotactic Focused Radiotherapy for Low-risk Prostate Cancer: Results of a Phase-II Trial
Paul Nguyen, Bertrand Donneaux, Céline Louis, Szusa Bodgal, Sven Philippi, Bérangère Frédérick, Sylvie Biver, Ludovic Harzé, Yves Lasar, Guillaume Vogin, Philippe Nickers | PO-1458 | ESTRO | 2023
Stereotactic APBI for Early-stage Breast Cancer: 3-year Outcomes of a Prospective Registry
Jonathan Cantalino, Monica Pernia Marin, David D’Ambrosio, Arica Hirsch, Malika Danner, Sonali Rudra, Simeng Suy, Sean Collins, Dawn Matsanka, Michael Good, Jing Feng, John Lamond, Deborah Markiewicz, Rachelle Lanciano, Olusola Obayomi-Davies, Brian Collins | PO-1249 | ESTRO | 2023
Robotic Radiosurgery for Benign Temporal Bone Paragangliomas: A Single-center Experience
Sofia Ramos et al | PO-1202 | ESTRO | 2023